Sunday, 1 May 2022

Reuters Global Healthcare: All Blue Capital in $773 million bid for Zymeworks

All Blue Capital in $773 million bid for Zymeworks

Investment firm All Blue Capital has approached Zymeworks Inc , a developer of antibody therapies for cancer, with a $773 million acquisition offer.

Moderna says its vaccine for ages under 6 will be ready for U.S. review in June

Moderna sought emergency use authorization from the FDA on Thursday.

As Beijing tightens COVID curbs, hard-hit Shanghai sees signs of life

The outbreak in Shanghai, which began in March, has been China's worst since the early months of the pandemic in 2020.

South Africa's Aspen COVID-19 vaccine plant risks closure after no orders, executive says

Africa's first COVID-19 vaccination plant, touted last year as a trailblazer for an under-vaccinated continent frustrated by sluggish Western handouts, risks shutting down after receiving not a single order, a company executive said on Saturday.

COVID's new Omicron sub-lineages can dodge immunity from past infection, study says

They are far less able to thrive in the blood of people vaccinated against COVID-19, South African scientists found.

Six Shanghai districts reach 'zero-COVID' status

China's financial hub of Shanghai has reined in COVID transmission risks at the community level, excluding cases in quarantine centres, with six of its 16 districts attaining zero-COVID status, an official said on Sunday.

Shanghai reports 38 new COVID deaths for April 30 versus 47 a day earlier

China's eastern commercial hub of Shanghai reported 38 new COVID-19 related deaths on April 30, down from 47 a day earlier, the local health authority said on Sunday.

Chinese Omicron-specific mRNA COVID vaccine candidate to be trialed in UAE

China's Suzhou Abogen Biosciences Co said its COVID-19 vaccine candidate using the messenger RNA (mRNA) technology and targeting the Omicron variant has obtained clinical trial approval in the United Arab Emirates.

Shanghai reports zero cases outside quarantined areas for April 29

China's Shanghai reported zero COVID-19 cases outside its quarantined areas for April 29, the first time since the recent outbreak in the eastern financial hub, according to local health authorities.

Pfizer's vaccines head Kathrin Jansen to retire this year

Pfizer Inc's vaccines head Kathrin Jansen, who led the development of the U.S. drugmaker's COVID-19 shot, has decided to retire later this year.

Related Videos

Moderna asks FDA to authorize COVID shot for kids

FDA pushes ahead to ban menthol cigarettes

Beijing ups COVID curbs, fears Shanghai-like misery

at